Longevity and health claims, checked against the actual studies
Category: Nutrition & Supplements
-

Growth hormone peptides reliably raise IGF-1, but only tesamorelin proves a real benefit. Here’s what the science shows on muscle, aging, and cancer risk.
-

The cholesterol paradox is real: those with the lowest cholesterol die soonest. But frailty, not protection, explains it, and LDL still causes heart disease.
-

Collagen peptides are the rare supplement with real human trials — but the skin benefit is modest and the joint evidence is stronger. Here’s the honest read.
-

Paper straws are toxic: a suspected carcinogen leaked into soda above the legal limit, and forever chemicals hit 90% of brands. Here’s why to ditch them.
-

BPC-157 has 31 years of rat data and not one completed human trial. Inside the healing peptide’s real evidence, the missing pharmacology, and the first RCT.
-

Research peptides are sold as “not for human use” — a legal fiction. Inside the thin human evidence, the arsenic found in vials, and where the law stands now.
-

A 2023 mouse study crowned taurine a longevity star; a 2025 correction reset the story. Here’s what the human evidence on taurine and aging honestly shows.
-

Senolytics clear the ‘zombie’ cells that drive aging. See what the dasatinib + quercetin bone trial really showed — and why it may hinge on one biomarker.
-

Low-dose rapamycin extended lifespan in mice and passed its first human safety trial. The honest science on rapamycin for longevity: hype versus real hope.
-

Urolithin A benefits are modest but real: a placebo-controlled trial shows this gut-microbiome metabolite boosts midlife muscle strength via mitophagy.